Sign in
4/A

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0000950170-23-069048

Director acquired 34,360 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Albers Jeffrey W. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-24 Conversion : show line 1 in the form +34,360 34,360 I

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-11-22 Grant or award : show line 2 in the form Stock Option (Right to Buy) +50,000 50,000 D
2023-11-24 Conversion : show line 3 in the form Series A Preferred Stock −859 0 I
Loading xslF345X05/ownership.xml…